NCT01309490 2025-07-29
Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients
Jewish General Hospital
Phase 1/2 Terminated
Clinical Trials
7 trialsNCT05717400 2024-12-31
Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy
M.D. Anderson Cancer Center
Phase 4 Terminated
NCT03760666 2022-08-08
A Study of Brequinar in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
Clear Creek Bio, Inc.
Phase 1/2 Terminated
NCT03585725 2021-09-27
A Pilot Investigator-Initiated Study of Ribavirin in Indolent Follicular Lymphoma and Mantle Cell Lymphoma
Weill Medical College of Cornell University
Phase EARLY_PHASE1 Terminated
NCT01821963 2020-09-24
Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT02717949 2019-01-08
Optimal
University of Texas Southwestern Medical Center
Phase 4 Terminated
NCT01056757 2015-11-04
Treatment With Ribavirin for Patients With Metastatic Breast Cancer
Jewish General Hospital
Phase 1/2 Terminated